Home ETF List About

Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / FundiShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerBTEC(USD) LSE
ETF TickerBTEK(GBP) LSE
ETF Ticker2B70(EUR) F
ETF Ticker2B70.DE(EUR) CXE
ETF TickerBTEC.LS(USD) CXE
ETF TickerBTEK.LS(GBP) CXE
ETF TickerBTEC.L(GBP) LSE
ETF TickerBTEK.L(GBP) LSE

Holdings detail for EDIT

Stock NameEditas Medicine Inc
TickerEDIT(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS28106W1036
LEI5299000AON4Q9NT2JE42

Show aggregate EDIT holdings

News associated with EDIT

Editas Medicine (NASDAQ:EDIT) Receives “Buy” Rating from HC Wainwright
HC Wainwright reaffirmed their buy rating on shares of Editas Medicine (NASDAQ:EDIT – Free Report) in a research note published on Friday morning,Benzinga reports. The brokerage currently has a $5.00 target price on the stock. A number of other research analysts also recently issued reports on EDIT. Wall Street Zen downgraded shares of Editas Medicine […] - 2025-09-08 03:10:44
Editas Medicine, Inc. (NASDAQ:EDIT) Receives Consensus Rating of “Hold” from Analysts
Editas Medicine, Inc. (NASDAQ:EDIT – Get Free Report) has received an average recommendation of “Hold” from the thirteen research firms that are currently covering the firm, Marketbeat.com reports. Two research analysts have rated the stock with a sell recommendation, seven have issued a hold recommendation, two have assigned a buy recommendation and two have assigned […] - 2025-08-06 05:14:49
Editas Medicine, Inc. (NASDAQ:EDIT) Receives $5.36 Average Target Price from Brokerages
Editas Medicine, Inc. (NASDAQ:EDIT – Get Free Report) has been assigned a consensus rating of “Hold” from the thirteen analysts that are presently covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell recommendation, seven have given a hold recommendation, two have given a buy recommendation and two have […] - 2025-06-20 02:20:16
Editas Medicine Reports 58% HBG1/2 Promoter Editing in Non-Human Primates Using High Efficiency tLNP Delivery Method
Editas Medicine reports 58% mean editing in HSCs after single tLNP dose, aiding sickle cell and beta thalassemia treatments. - 2025-06-12 03:10:24
Editas Medicine, Inc. (NASDAQ:EDIT) Shares Sold by Hennion & Walsh Asset Management Inc.
Hennion & Walsh Asset Management Inc. trimmed its position in shares of Editas Medicine, Inc. (NASDAQ:EDIT – Free Report) by 3.8% during the first quarter, Holdings Channel reports. The firm owned 257,460 shares of the company’s stock after selling 10,298 shares during the quarter. Hennion & Walsh Asset Management Inc.’s holdings in Editas Medicine were […] - 2025-06-10 04:58:49
Two Sigma Advisers LP Purchases 528,000 Shares of Editas Medicine, Inc. (NASDAQ:EDIT)
Two Sigma Advisers LP raised its stake in Editas Medicine, Inc. (NASDAQ:EDIT – Free Report) by 46.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,657,000 shares of the company’s stock after purchasing an additional 528,000 shares during the period. […] - 2025-05-29 05:16:52
Editas Medicine, Inc. (NASDAQ:EDIT) Receives $5.36 Consensus PT from Brokerages
Editas Medicine, Inc. (NASDAQ:EDIT – Get Free Report) has earned an average rating of “Hold” from the fourteen research firms that are covering the firm, MarketBeat reports. Two analysts have rated the stock with a sell recommendation, eight have issued a hold recommendation, two have given a buy recommendation and two have issued a strong […] - 2025-05-26 02:48:57
Stifel Financial Corp Sells 287,718 Shares of Editas Medicine, Inc. (NASDAQ:EDIT)
Stifel Financial Corp lessened its position in shares of Editas Medicine, Inc. (NASDAQ:EDIT – Free Report) by 46.0% during the 4th quarter, HoldingsChannel reports. The fund owned 337,158 shares of the company’s stock after selling 287,718 shares during the quarter. Stifel Financial Corp’s holdings in Editas Medicine were worth $428,000 at the end of the […] - 2025-05-13 04:50:58
Invesco Ltd. Has $127,000 Stake in Editas Medicine, Inc. (NASDAQ:EDIT)
Invesco Ltd. increased its stake in Editas Medicine, Inc. (NASDAQ:EDIT – Free Report) by 9.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 100,164 shares of the company’s stock after acquiring an additional 8,448 shares during the quarter. Invesco Ltd.’s […] - 2025-05-06 04:28:46
Editas Medicine (NASDAQ:EDIT) Upgraded at HC Wainwright
HC Wainwright upgraded shares of Editas Medicine (NASDAQ:EDIT – Free Report) to a strong-buy rating in a research report sent to investors on Monday, MarketBeat Ratings reports. The brokerage currently has $3.00 price objective on the stock. Editas Medicine Stock Up 6.5 % Shares of EDIT stock opened at $1.65 on Monday. The firm has […] - 2025-05-01 04:40:50
Cantor Fitzgerald Upgrades Editas Medicine (NASDAQ:EDIT) to Strong-Buy
Editas Medicine (NASDAQ:EDIT – Get Free Report) was upgraded by Cantor Fitzgerald from a “hold” rating to a “strong-buy” rating in a research report issued on Tuesday,Zacks.com reports. Separately, HC Wainwright initiated coverage on Editas Medicine in a research report on Monday. They set a “buy” rating and a $3.00 price objective for the company. […] - 2025-05-01 02:38:48
XTX Topco Ltd Purchases 52,498 Shares of Editas Medicine, Inc. (NASDAQ:EDIT)
XTX Topco Ltd boosted its position in shares of Editas Medicine, Inc. (NASDAQ:EDIT – Free Report) by 99.9% during the 4th quarter, HoldingsChannel.com reports. The firm owned 105,056 shares of the company’s stock after acquiring an additional 52,498 shares during the quarter. XTX Topco Ltd’s holdings in Editas Medicine were worth $133,000 at the end […] - 2025-04-30 05:22:59
Raymond James Financial Inc. Takes Position in Editas Medicine, Inc. (NASDAQ:EDIT)
Raymond James Financial Inc. purchased a new position in shares of Editas Medicine, Inc. (NASDAQ:EDIT – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 238,967 shares of the company’s stock, valued at approximately $303,000. A number of other institutional […] - 2025-04-10 04:14:58
Editas Medicine, Inc. (NASDAQ:EDIT) Receives Average Rating of “Hold” from Brokerages
Editas Medicine, Inc. (NASDAQ:EDIT – Get Free Report) has been given an average rating of “Hold” by the fourteen analysts that are currently covering the stock, MarketBeat reports. Two investment analysts have rated the stock with a sell recommendation, nine have given a hold recommendation and three have issued a buy recommendation on the company. […] - 2025-03-12 04:56:52
Ieq Capital LLC Makes New Investment in Editas Medicine, Inc. (NASDAQ:EDIT)
Ieq Capital LLC acquired a new stake in shares of Editas Medicine, Inc. (NASDAQ:EDIT – Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 24,634 shares of the company’s stock, valued at approximately $31,000. A number of other institutional […] - 2025-03-03 06:50:57
Analysts Set Editas Medicine, Inc. (NASDAQ:EDIT) Price Target at $7.00
Shares of Editas Medicine, Inc. (NASDAQ:EDIT – Get Free Report) have received a consensus rating of “Hold” from the fourteen brokerages that are currently covering the firm, MarketBeat reports. Two equities research analysts have rated the stock with a sell recommendation, nine have assigned a hold recommendation and three have issued a buy recommendation on […] - 2025-02-18 04:44:58

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) EDIT holdings

DateNumber of EDIT Shares HeldBase Market Value of EDIT SharesLocal Market Value of EDIT SharesChange in EDIT Shares HeldChange in EDIT Base ValueCurrent Price per EDIT Share HeldPrevious Price per EDIT Share Held
2025-11-11 (Tuesday)61,643USD 163,970EDIT holding increased by 8630USD 163,9700USD 8,630 USD 2.65999 USD 2.51999
2025-11-10 (Monday)61,643EDIT holding increased by 164USD 155,340EDIT holding increased by 3487USD 155,340164USD 3,487 USD 2.51999 USD 2.47
2025-11-07 (Friday)61,479USD 151,853EDIT holding decreased by -13526USD 151,8530USD -13,526 USD 2.47 USD 2.69001
2025-11-06 (Thursday)61,479EDIT holding increased by 164USD 165,379EDIT holding decreased by -5077USD 165,379164USD -5,077 USD 2.69001 USD 2.78
2025-11-05 (Wednesday)61,315USD 170,456USD 170,4560USD 0 USD 2.78 USD 2.78
2025-11-04 (Tuesday)61,315EDIT holding increased by 164USD 170,456EDIT holding decreased by -16666USD 170,456164USD -16,666 USD 2.78 USD 3.06
2025-11-03 (Monday)61,151USD 187,122EDIT holding decreased by -1223USD 187,1220USD -1,223 USD 3.06 USD 3.08
2025-10-31 (Friday)61,151USD 188,345EDIT holding increased by 4280USD 188,3450USD 4,280 USD 3.08 USD 3.01001
2025-10-30 (Thursday)61,151EDIT holding increased by 820USD 184,065EDIT holding increased by 659USD 184,065820USD 659 USD 3.01001 USD 3.04
2025-10-29 (Wednesday)60,331EDIT holding increased by 328USD 183,406EDIT holding decreased by -6804USD 183,406328USD -6,804 USD 3.04 USD 3.17001
2025-10-28 (Tuesday)60,003USD 190,210EDIT holding decreased by -4800USD 190,2100USD -4,800 USD 3.17001 USD 3.25
2025-10-27 (Monday)60,003USD 195,010EDIT holding decreased by -28201USD 195,0100USD -28,201 USD 3.25 USD 3.72
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of EDIT by Blackrock for IE00BYXG2H39

Show aggregate share trades of EDIT

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-10BUY1642.7052.470 2.494USD 409 2.18
2025-11-06BUY1642.7902.620 2.637USD 432 2.18
2025-11-04BUY1642.9802.770 2.791USD 458 2.17
2025-10-30BUY8203.0652.940 2.953USD 2,421 2.16
2025-10-29BUY3283.0403.200 3.184USD 1,044 2.15
2025-10-22SELL-6443.5703.870 3.840USD -2,473 2.12 Loss of -1,109 on sale
2025-10-20BUY3224.1404.275 4.262USD 1,372 2.10
2025-10-17BUY8033.7703.980 3.959USD 3,179 2.09
2025-10-15BUY1,2724.0604.170 4.159USD 5,290 2.08
2025-10-03BUY9873.9204.050 4.037USD 3,985 2.06
2025-10-02BUY1413.8903.920 3.917USD 552 2.05
2025-09-30BUY2823.4703.620 3.605USD 1,017 2.03
2025-09-26BUY2823.2403.260 3.258USD 919 2.02
2025-09-25BUY2823.2303.370 3.356USD 946 2.01
2025-09-24BUY13.3703.575 3.555USD 4 2.00
2025-09-18BUY1403.0003.073 3.066USD 429 2.00
2025-09-17BUY4232.7202.900 2.882USD 1,219 1.99
2025-08-20SELL-5642.6702.770 2.760USD -1,557 1.97 Loss of -443 on sale
2025-07-30BUY5522.5202.715 2.695USD 1,488 1.95
2025-07-17SELL-2782.7302.890 2.874USD -799 1.88 Loss of -276 on sale
2025-07-11SELL-1,1282.8803.090 3.069USD -3,462 1.86 Loss of -1,367 on sale
2025-07-07BUY4232.5402.627 2.618USD 1,108 1.83
2025-07-02BUY7,7002.5602.875 2.843USD 21,895 1.82
2025-06-11BUY2802.0302.190 2.174USD 609 1.80
2025-06-10BUY2802.1002.230 2.217USD 621 1.79
2025-06-04SELL-1401.8201.850 1.847USD -259 1.79 Loss of -8 on sale
2025-04-23BUY1401.5601.690 1.677USD 235 1.86
2025-04-10SELL-1,1201.1101.130 1.128USD -1,263 1.91 Profit of 881 on sale
2025-04-08SELL-1400.9801.070 1.061USD -149 1.93 Profit of 122 on sale
2025-04-07SELL-1401.0001.050 1.045USD -146 1.95 Profit of 126 on sale
2025-04-04SELL-7001.0301.150 1.138USD -797 1.96 Profit of 572 on sale
2025-04-01BUY5601.1301.180 1.175USD 658 1.98
2025-03-31SELL-4201.1601.240 1.232USD -517 1.99 Profit of 316 on sale
2025-03-14SELL-2,2401.4601.500 1.496USD -3,351 2.08 Profit of 1,319 on sale
2025-03-07SELL-2801.7201.829 1.818USD -509 2.13 Profit of 86 on sale
2025-03-04SELL-1401.7601.810 1.805USD -253 2.14 Profit of 47 on sale
2025-02-25BUY2801.8601.980 1.968USD 551 2.17
2025-02-20SELL-1402.0602.860 2.780USD -389 2.17 Loss of -85 on sale
2025-02-13BUY4201.2301.250 1.248USD 524 2.21
2025-02-12BUY1401.1901.220 1.217USD 170 2.23
2025-02-11BUY5601.1801.210 1.207USD 676 2.26
2024-12-30SELL-7001.2001.270 1.263USD -884 2.68 Profit of 992 on sale
2024-11-18SELL-2,1002.5202.690 2.673USD -5,613 3.15 Profit of 1,010 on sale
2024-11-08SELL-1403.1203.235 3.223USD -451 3.16 Loss of -9 on sale
2024-10-21SELL-1403.7603.800 3.796USD -531 0.00 Loss of -531 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of EDIT

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19456,1862,0001,110,56041.1%
2025-09-18363,4731,5751,991,61218.3%
2025-09-17231,7903,618665,41734.8%
2025-09-16392,7611,0751,278,58930.7%
2025-09-15203,749210472,70743.1%
2025-09-12137,2177,967551,43124.9%
2025-09-11169,4670685,33124.7%
2025-09-10186,715200770,42224.2%
2025-09-09149,3110681,49221.9%
2025-09-08197,4840832,26423.7%
2025-09-05350,547501,088,08532.2%
2025-09-04205,9254,399534,13638.6%
2025-09-03227,54011,202790,19228.8%
2025-09-02212,188390490,71143.2%
2025-08-29115,9041,993519,13822.3%
2025-08-28113,942950315,93736.1%
2025-08-2788,6330301,13729.4%
2025-08-2684,2150292,74928.8%
2025-08-25156,1920506,12530.9%
2025-08-22186,6600608,70730.7%
2025-08-21141,0680367,26738.4%
2025-08-20144,383102461,25231.3%
2025-08-19192,249153723,10726.6%
2025-08-18238,444100831,71428.7%
2025-08-15397,9864191,510,66326.3%
2025-08-14248,1541,119858,03328.9%
2025-08-131,234,76522,5124,431,67527.9%
2025-08-12189,4541,307539,63135.1%
2025-08-11165,15822,422733,85922.5%
2025-08-08492,64124,0021,208,61640.8%
2025-08-07124,397339397,68531.3%
2025-08-06150,3505444,36333.8%
2025-08-05217,85119716,26930.4%
2025-08-04244,0780630,32238.7%
2025-08-01324,485107715,19845.4%
2025-07-31388,4872,025930,77541.7%
2025-07-30266,68448,2231,135,80123.5%
2025-07-29426,87231,3732,052,07920.8%
2025-07-28243,9381,961934,42326.1%
2025-07-25241,8055,832673,64435.9%
2025-07-24409,5081,5081,209,43333.9%
2025-07-23446,8489,4021,259,11035.5%
2025-07-22470,7982971,393,92633.8%
2025-07-211,128,0757243,405,49633.1%
2025-07-18311,3748,7501,197,03726.0%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.